Document Type : Review Article
Authors
1 Student Research Committee, School of Public Health, Kerman University of Medical Sciences, Kerman, Iran & Physiology Research Center, Kerman University of Medical Sciences, Kerman, Iran
2 Student Research Committee, School of Public Health, Kerman University of Medical Sciences, Kerman, Iran & Department of Nutrition, School of Public Health, Kerman University of Medical Sciences, Kerman, Iran
3 Department of Clinical Nutrition and Dietetics, Faculty of Nutrition Sciences and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Abstract
Background: Blood lipid profiles are known as one of the most important factors in health disorders such as obesity and diabetes, which mostly end in cardiovascular diseases (CVDs) such as coronary heart disease (CHD). Purslane, as an edible herbal plant has shown to have beneficial components for dyslipidemia treatment. This study aimed to evaluate the effects of purslane supplementation on blood lipid profiles in the adult population.
Methods: The terms Portulaca, Portulaca, Portulaca oleracea, and Purslane together with lipid profile ingredients including triglyceride (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) were searched in the following databases until 30 October 2020: PubMed, MEDLINE, Scopus, EMBASE, Science Direct, and SID. A meta-analysis was conducted with eight randomized controlled trials (RCTs) on 444 patients using the STATA software version 14.
Results: Eight eligible studies on 444 patients were identified for the present study. The purslane supplementation caused significant reduction in TG (-18.55 mg/dL, 95% CI [-31.712, -5.388]), TC (-8.43 mg/dL; 95% CI [-14.99, -1.87]), and LDL-C (-6.45 mg/dL, 95% CI [-11.13, -1.77]); however, no significant effect was observed on HDL-C (1.28 mg/dL, 95% CI [-0.56, 2.93], P = 0.170).
Conclusion: Our results suggested that purslane supplementation could reduce TG, TC, and LDL-C. However, no significant effect was observed on HDL-C.
Keywords
Sahebkar A. Effect of purslane on blood lipids and glucose: A
systematic review and meta-analysis of randomized controlled
trials. Phytother Res. 2019;33(1):3-12. doi: 10.1002/ptr.6203.
2. Mayoral LP, Andrade GM, Mayoral EP, Huerta TH, Canseco SP,
Rodal Canales FJ, et al. Obesity subtypes, related biomarkers
& heterogeneity. Indian J Med Res. 2020;151(1):11-21. doi:
10.4103/ijmr.IJMR_1768_17.
3. Hruby A, Hu FB. The epidemiology of obesity: a big picture.
Pharmacoeconomics. 2015;33(7):673-89. doi: 10.1007/
s40273-014-0243-x.
4. James WP. The epidemiology of obesity: the size of
the problem. J Intern Med. 2008;263(4):336-52. doi:
10.1111/j.1365-2796.2008.01922.x.
5. Biro FM, Wien M. Childhood obesity and adult morbidities.
Am J Clin Nutr. 2010;91(5):1499S-505S. doi: 10.3945/
ajcn.2010.28701B.
6. van Dam RM, Willett WC, Manson JE, Hu FB. The relationship
between overweight in adolescence and premature
death in women. Ann Intern Med. 2006;145(2):91-7. doi:
10.7326/0003-4819-145-2-200607180-00006.
7. World Health Organization (WHO). Obesity: Preventing and
Managing the Global Epidemic. WHO; 2000.
8. Wright SM, Aronne LJ. Causes of obesity. Abdom Imaging.
2012;37(5):730-2. doi: 10.1007/s00261-012-9862-x.
9. Sabzghabaee AM, Kelishadi R, Jelokhanian H, Asgary S,
Ghannadi A, Badri S. Clinical effects of Portulaca oleracea
seeds on dyslipidemia in obese adolescents: a triple-blinded
randomized controlled trial. Med Arch. 2014;68(3):195-9.
doi: 10.5455/medarh.2014.68.195-199.
10. Talaei B, Mozaffari-Khosravi H, Jalali BA, Mahammadi SM,
Najarzadeh A, Fallahzadeh H. The effect of ginger on blood
glucose, lipid and lipoproteins in patients with type 2 diabetes:
a double-blind randomized clinical controlled trial. J Shahid
Sadoughi Univ Med Sci. 2012;20(3):383-95. [Persian].
11. Talaei B, Bahreini S. The effects of cinnamon on diabetes
mellitus: a narrative review. Int Electron J Med. 2019;8(1):37-
46. doi: 10.31661/iejm871.
12. Ezekwe MO, Omara-Alwala TR, Membrahtu T. Nutritive
characterization of purslane accessions as influenced by
planting date. Plant Foods Hum Nutr. 1999;54(3):183-91. doi:
10.1023/a:1008101620382.
13. Mohamed AI, Hussein AS. Chemical composition of purslane
(Portulaca oleracea). Plant Foods Hum Nutr. 1994;45(1):1-9.
doi: 10.1007/bf01091224.
14. Simopoulos AP. Omega-3 fatty acids in health and disease and
in growth and development. Am J Clin Nutr. 1991;54(3):438-
63. doi: 10.1093/ajcn/54.3.438.
15. Obied WA, Mohamoud EN, Mohamed OSA. Portulaca
oleracea (purslane): nutritive composition and clinicopathological
effects on Nubian goats. Small Rumin Res.
2003;48(1):31-6. doi: 10.1016/s0921-4488(02)00182-7.
16. Islam MW, Zakaria MN, Radhakrishnan R, Habibullah M,
Chan K. Evaluation of analgesic activity of the aerial parts
of Portulaca oleracea V. sativa and its comparison with two
related species. J Pharm Pharmacol. 1998;50(Suppl 9):226.
doi: 10.1111/j.2042-7158.1998.tb02426.x.
17. Oh KB, Chang IM, Hwang KJ, Mar W. Detection of antifungal
activity in Portulaca oleracea by a single-cell bioassay system.
Phytother Res. 2000;14(5):329-32. doi: 10.1002/1099-
1573(200008)14:5 < 329::aid-ptr581 > 3.0.co;2-5.
18. Bensky D, Clavey S, Stõger E. Materia Medica. Chinese Herbal
Medicine; 2004. p. 3-6.
19. Shanker N, Debnath S. Impact of dehydration of purslane on
retention of bioactive molecules and antioxidant activity. J
Food Sci Technol. 2015;52(10):6631-8. doi: 10.1007/s13197-
015-1741-3.
20. Sultana A, Rahman K. Portulaca oleracea Linn. A global
Panacea with ethno-medicinal and pharmacological
potential. Int J Pharm Pharm Sci. 2013;5(2):33-9.
21. Lan S, Lu FE. Effects of Portulaca oleracea on insulin resistance
in rats with type 2 diabetes mellitus. Chin J Integr Med.
2003;9(4):289-92. doi: 10.1007/bf02838618.
22. Movahedian A, Ghannadi A, Vashirnia M. Hypocholesterolemic
effects of purslane extract on serum lipids in rabbits fed with
high cholesterol levels. Int J Pharmacol. 2007;3(3):285-9.
23. Dehghan F, Soori R, Gholami K, Abolmaesoomi M, Yusof
A, Muniandy S, et al. Purslane (Portulaca oleracea) seed
consumption and aerobic training improves biomarkers
associated with atherosclerosis in women with type 2 diabetes
(T2D). Sci Rep. 2016;6:37819. doi: 10.1038/srep37819.
24. Bedakhanian M, Entezari MH, Ghanadian M, Askari G,
Maracy MR. The effects of Portulaca oleracea on lipid profile,
C-reactive protein, and fasting blood glucose in men with
metabolic syndrome: a double-blind randomized clinical
trial. mui-jhsr. 2017;12(4):478-83. doi: 10.22122/jhsr.
v12i4.2765. [Persian].
25. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting
items for systematic reviews and meta-analyses: the PRISMA
statement. PLoS Med. 2009;6(7):e1000097. doi: 10.1371/
journal.pmed.1000097.
26. Abstrackr. Available from: https://github.com/bwallace/
abstrackr-web.
27. Halpern SH, Douglas MJ. Appendix: Jadad scale for reporting
randomized controlled trials. In: Evidence-Based Obstetric
Anesthesia. Oxford, UK: Blackwell Publishing Ltd; 2005. p.
237-8.
28. Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page
MJ, et al. Cochrane Handbook for Systematic Reviews of
Interventions. John Wiley & Sons; 2019.
29. Deeks JJ, Higgins J, Altman DG, Green S. Cochrane
Handbook for Systematic Reviews of Interventions. Version
5.1. 0 (Updated March 2011). The Cochrane Collaboration;
2011. p. 2.
30. El-Sayed MI. Effects of Portulaca oleracea L. seeds in
treatment of type-2 diabetes mellitus patients as adjunctive
and alternative therapy. J Ethnopharmacol. 2011;137(1):643-
51. doi: 10.1016/j.jep.2011.06.020.
31. Esmaillzadeh A, Zakizadeh E, Faghihimani E, Gohari
M, Jazayeri S. The effect of purslane seeds on glycemic
status and lipid profiles of persons with type 2 diabetes: a
randomized controlled cross-over clinical trial. J Res Med Sci.
2015;20(1):47-53.
32. Farzanegi P. Impact of the synchronization of Portulaca
oleracea and aerobic training on levels of MMP2 and
MMP9 and TIMP1 in diabetic women type II. Res Mol Med.
2014;2(2):34-9. doi: 10.18869/acadpub.rmm.2.2.34.
33. Gheflati A, Adelnia E, Nadjarzadeh A. The clinical effects of
purslane (Portulaca oleracea) seeds on metabolic profiles in
patients with nonalcoholic fatty liver disease: a randomized
controlled clinical trial. Phytother Res. 2019;33(5):1501-9.
doi: 10.1002/ptr.6342.
Journal of Kerman University of Medical Sciences. Volume 29, Number 6, 2022 585
Purslane and lipid profile
34. Wainstein J, Landau Z, Bar Dayan Y, Jakubowicz D, Grothe
T, Perrinjaquet-Moccetti T, et al. Purslane extract and glucose
homeostasis in adults with type 2 diabetes: a double-blind,
placebo-controlled clinical trial of efficacy and safety. J Med
Food. 2016;19(2):133-40. doi: 10.1089/jmf.2015.0090.
35. Egger M, Davey-Smith G, Altman D. Systematic Reviews in
Health Care: Meta-Analysis in Context. John Wiley & Sons;
2008.
36. Acedo JZ, Reyes C, Rodriguez EB. Health-promoting lipids from
purslane (Portulaca oleracea L.) isolation, characterization,
quantification and in vivo assay for angiogenic activity.
Philipp Agric Sci. 2012;95(4):327-4.
37. Reid D. Chinese Herbal Medicine. Hong Kong: Hai Feng
Publication; 1987.
38. Palaniswamy UR, Bible BB, McAvoy RJ. Oxalic acid
concentrations in Purslane (Portulaca oleraceae L.) is altered
by the stage of harvest and the nitrate to ammonium ratios in
hydroponics. Sci Hortic. 2004;102(2):267-75. doi: 10.1016/j.
scienta.2004.01.006.
39. Bataille P, Fournier A. Calcium Supply in Calcic Lithiasis.
Médecine et Nutrition (France); 2001.
40. Zhang Y, Chen J, Ma XM, Shi YP. Simultaneous determination
of flavonoids in Ixeridium gracile by micellar electrokinetic
chromatography. J Pharm Biomed Anal. 2007;45(5):742-6.
doi: 10.1016/j.jpba.2007.08.014.
41. Hertog MG, Feskens EJ, Hollman PC, Katan MB,
Kromhout D. Dietary antioxidant flavonoids and risk
of coronary heart disease: the Zutphen Elderly Study.
Lancet. 1993;342(8878):1007-11. doi: 10.1016/0140-
6736(93)92876-u.
42. Xu X, Yu L, Chen G. Determination of flavonoids in Portulaca
oleracea L. by capillary electrophoresis with electrochemical
detection. J Pharm Biomed Anal. 2006;41(2):493-9. doi:
10.1016/j.jpba.2006.01.013.
43. McKenney JM, Sica D. Prescription omega-3 fatty acids for the
treatment of hypertriglyceridemia. Am J Health Syst Pharm.
2007;64(6):595-605. doi: 10.2146/ajhp060164.
44. Skulas-Ray AC, Kris-Etherton PM, Harris WS, Vanden
Heuvel JP, Wagner PR, West SG. Dose-response effects of
omega-3 fatty acids on triglycerides, inflammation, and
endothelial function in healthy persons with moderate
hypertriglyceridemia. Am J Clin Nutr. 2011;93(2):243-52. doi:
10.3945/ajcn.110.003871.
45. Nestel PJ. Fish oil and cardiovascular disease: lipids and
arterial function. Am J Clin Nutr. 2000;71(1 Suppl):228S-31S.
doi: 10.1093/ajcn/71.1.228S.
46. Abumweis SS, Barake R, Jones PJ. Plant sterols/stanols as
cholesterol lowering agents: a meta-analysis of randomized
controlled trials. Food Nutr Res. 2008;52. doi: 10.3402/fnr.
v52i0.1811.
47. Daniel M. Medicinal Plants: Chemistry and Properties.
Science Publishers; 2006.
)